Literature DB >> 18259037

Shared constitutional risks for maternal vascular-related pregnancy complications and future cardiovascular disease.

Anne L Berends1, Christianne J M de Groot, Eric J Sijbrands, Mark P S Sie, Sofie H Benneheij, Richard Pal, Roger Heydanus, Ben A Oostra, Cornelia M van Duijn, Eric A P Steegers.   

Abstract

Maternal predisposition to vascular and metabolic disease may underlie both vascular-related pregnancy complications, such as preeclampsia and intrauterine growth restriction, as well as future maternal cardiovascular disease. We aimed to substantiate this hypothesis with biochemical and anthropometric evidence by conducting an intergenerational case-control study in a Dutch isolated population including 106 women after preeclampsia or intrauterine growth restriction (median follow-up: 7.1 years) and their fathers (n=43) and mothers (n=64), as well as 106 control subjects after uncomplicated pregnancies with their fathers (n=51) and mothers (n=68). Cardiovascular risk profiles were assessed, including fasting glucose, lipids, anthropometrics, blood pressure, intima-media thickness, and metabolic syndrome. We found significantly higher fasting glucose levels, larger waist circumferences, and a 5-fold increased prevalence of hypertension in women with a history of preeclampsia as compared with control subjects (P<0.001). Likewise, their parents had higher glucose levels than control parents (P<0.05). Their mothers had larger waist circumferences and higher blood pressures (P<0.05). Also, women after pregnancies complicated by intrauterine growth restriction had higher glucose levels and increased prevalence of hypertension (P<0.01). Their fathers showed higher glucose levels as well (P<0.05). Mean carotid intima-media thickness was increased in a subset of women after preeclampsia diagnosed with chronic hypertension as compared with those without hypertension (P<0.01). Metabolic syndrome was more prevalent both in women with a history of preeclampsia and their mothers (P<0.05). We demonstrated intergenerational similarities in cardiovascular risk profiles between women after preeclampsia or intrauterine growth restriction and their parents. These findings suggest shared constitutional risks for vascular-related pregnancy complications and future cardiovascular disease.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18259037     DOI: 10.1161/HYPERTENSIONAHA.107.101873

Source DB:  PubMed          Journal:  Hypertension        ISSN: 0194-911X            Impact factor:   10.190


  32 in total

1.  Maternal plasma concentrations of angiogenic/anti-angiogenic factors are of prognostic value in patients presenting to the obstetrical triage area with the suspicion of preeclampsia.

Authors:  Tinnakorn Chaiworapongsa; Roberto Romero; Zeynep Alpay Savasan; Juan Pedro Kusanovic; Giovanna Ogge; Eleazar Soto; Zhong Dong; Adi Tarca; Bhatti Gaurav; Sonia S Hassan
Journal:  J Matern Fetal Neonatal Med       Date:  2011-08-09

Review 2.  Challenges of studying drugs in pregnancy for off-label indications: pravastatin for preeclampsia prevention.

Authors:  Kirsten Lawrence Cleary; Kelly Roney; Maged Costantine
Journal:  Semin Perinatol       Date:  2014-10-12       Impact factor: 3.300

Review 3.  Preclinical atherosclerosis at the time of pre-eclamptic pregnancy and up to 10 years postpartum: systematic review and meta-analysis.

Authors:  N M Milic; J Milin-Lazovic; T L Weissgerber; G Trajkovic; W M White; V D Garovic
Journal:  Ultrasound Obstet Gynecol       Date:  2017-01       Impact factor: 7.299

4.  Cardiovascular system during the postpartum state in women with a history of preeclampsia.

Authors:  Caroline S Evans; Linda Gooch; Deborah Flotta; David Lykins; Robert W Powers; Douglas Landsittel; James M Roberts; Sanjeev G Shroff
Journal:  Hypertension       Date:  2011-05-23       Impact factor: 10.190

5.  Should We Add Pravastatin to Aspirin for Preeclampsia Prevention in High-risk Women?

Authors:  Caroline C Marrs; Maged M Costantine
Journal:  Clin Obstet Gynecol       Date:  2017-03       Impact factor: 2.190

6.  Offspring preterm birth and birth size are related to long-term risk of maternal diabetes.

Authors:  Klara Vinsand Naver; Niels Jørgen Secher; Per Glud Ovesen; Anders Gorst-Rasmussen; Søren Lundbye-Christensen; Lisbeth Nilas
Journal:  Eur J Epidemiol       Date:  2013-04-24       Impact factor: 8.082

7.  Pravastatin to prevent obstetrical complications in women with antiphospholipid syndrome.

Authors:  Maged M Costantine
Journal:  J Clin Invest       Date:  2016-07-25       Impact factor: 14.808

8.  Postpartum healthcare after gestational diabetes and hypertension.

Authors:  Deborah B Ehrenthal; Kristin Maiden; Stephanie Rogers; Amy Ball
Journal:  J Womens Health (Larchmt)       Date:  2014-08-04       Impact factor: 2.681

Review 9.  Cardiovascular disease risk in women with pre-eclampsia: systematic review and meta-analysis.

Authors:  Morven Caroline Brown; Kate Elizabeth Best; Mark Stephen Pearce; Jason Waugh; Stephen Courtenay Robson; Ruth Bell
Journal:  Eur J Epidemiol       Date:  2013-02-09       Impact factor: 8.082

10.  Diabetes: hypertension during pregnancy and future diabetes mellitus.

Authors:  Maisa Feghali; Menachem Miodovnik
Journal:  Nat Rev Endocrinol       Date:  2013-06-04       Impact factor: 43.330

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.